MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates.

Antimicrobial Agents and Chemotherapy
M MaurinDidier Raoult

Abstract

We assessed in vitro the antibiotic susceptibilities of 14 Bartonella isolates of the species B. quintana, B. vinsonii, B. henselae, and B. elizabethae. Columbia agar base supplemented with 5% horse blood was used as the antibiotic assay medium. Bacterial growth could be evaluated within 5 days after incubation of the plates at 37 degrees C in a 5% carbon dioxide atmosphere. The MICs at which 90% of isolates are inhibited (MIC90s) were 0.06 microgram/ml for penicillin G and amoxicillin and 0.25 microgram/ml for ticarcillin and cefotaxime. The MIC90s of oxacillin and cephalothin were 4 and 16 micrograms/ml, respectively. The MIC90s ranged from 1 to 4 micrograms/ml for aminoglycosides. Erythromycin, doxycycline, and rifampin displayed MIC90s of 0.12, 0.12, and 0.25 microgram/ml, respectively. MIC90s were 1 and 5 micrograms/ml for trimethoprim-and sulfamethoxazole, respectively, 64 micrograms/ml for fosfomycin, and 16 micrograms/ml for colistin and vancomycin. The study confirms the high levels of in vitro susceptibility of Bartonella agents to antibiotics.

References

Nov 26, 1992·The New England Journal of Medicine·B A PerkinsD J Wear
Dec 3, 1992·The New England Journal of Medicine·J E KoehlerJ W Tappero
Mar 1, 1992·Archives of Internal Medicine·L N SlaterK W Min
Apr 1, 1992·American Journal of Diseases of Children·P J Collio
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D LuceyK S Greisen
May 4, 1992·The Medical Journal of Australia·R R Molnar
Apr 6, 1991·JAMA : the Journal of the American Medical Association·H P Holley
Dec 6, 1990·The New England Journal of Medicine·D A RelmanL S Tompkins
Dec 6, 1990·The New England Journal of Medicine·L N SlaterD W Coody
Jun 1, 1990·Archives of Dermatology·C J CockerellP M Tierno
Aug 11, 1989·JAMA : the Journal of the American Medical Association·C W BogueK M Edwards
Nov 1, 1985·American Journal of Diseases of Children·H A Carithers
Feb 1, 1969·Journal of Bacteriology·W F MyersC L Wisseman
Oct 1, 1983·Journal of Clinical Microbiology·A von Graevenitz, C Bucher
Jun 1, 1984·Antimicrobial Agents and Chemotherapy·W F MyersC L Wisseman
Aug 1, 1981·Antimicrobial Agents and Chemotherapy·V L SutterY Y Kwok
Feb 16, 1995·The New England Journal of Medicine·M DrancourtD Raoult
Apr 1, 1993·Journal of Clinical Microbiology·J S DalyS P O'Connor
Oct 1, 1993·Human Pathology·T L HadfieldC Levy
Mar 1, 1993·Annals of Internal Medicine·M J DolanD Drehner
Mar 1, 1993·Annals of Internal Medicine·J W TapperoP E LeBoit
Mar 1, 1993·Journal of Clinical Microbiology·D H SpachD J Brenner
Jul 1, 1993·The New England Journal of Medicine·K M ZangwillJ D Wenger
Jul 1, 1995·The Journal of Antimicrobial Chemotherapy·D MussoD Raoult

❮ Previous
Next ❯

Citations

Jul 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M MaurinD Raoult
Jul 19, 2006·Journal of Feline Medicine and Surgery·Jane BruntUNKNOWN Academy of Feline Medicine Advisory Panel
Dec 23, 1998·Survey of Ophthalmology·R R Ghauri, A G Lee
Jun 1, 1997·International Journal of Antimicrobial Agents·M Maurin, D Raoult
Dec 20, 1997·The New England Journal of Medicine·J E KoehlerJ W Tappero
Aug 31, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C FoucaultD Raoult
Oct 29, 1998·AIDS·S GasquetD Raoult
Jan 1, 1997·The Pediatric Infectious Disease Journal·J W BassD A Person
Feb 1, 1997·The Pediatric Infectious Disease Journal·J W BassD A Person
Dec 1, 2007·International Ophthalmology Clinics·Michael Vaphiades, Karl C Golnik
Aug 1, 1997·Australian and New Zealand Journal of Medicine·N McGrathW Taylor
May 10, 2008·Journal of Veterinary Internal Medicine·J R CrossR B Duncan
Oct 16, 2001·Antimicrobial Agents and Chemotherapy·M Maurin, D Raoult
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Jean-Marc RolainDidier Raoult
May 25, 2004·Antimicrobial Agents and Chemotherapy·J M RolainD Raoult
Jan 5, 2002·Clinical and Diagnostic Laboratory Immunology·V JacomoDidier Raoult
Jan 9, 2001·Clinical Microbiology Reviews·P Brouqui, D Raoult
Mar 24, 1999·Ryōikibetsu shōkōgun shirīzu·K WatanabeA Kitahara
Dec 7, 2000·Clinical Pharmacokinetics·I Lutsar, I R Friedland
Dec 8, 2010·Future Microbiology·Silpak Biswas, Jean-Marc Rolain
Mar 10, 2004·Journal of the American Animal Hospital Association·Edward B BreitschwerdtMichael D Willard
Oct 30, 2004·Seminars in Ophthalmology·Karl C Golnik
Jun 23, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hidehiro TsuneokaKiyoshi Ichihara
Jul 16, 2008·International Journal of Antimicrobial Agents·Silpak BiswasJean-Marc Rolain
Sep 25, 2007·Diagnostic Microbiology and Infectious Disease·Dorothee Maria GescherAnnette Moter
Feb 27, 2007·Veterinary Microbiology·Jonathan A WernerBruno B Chomel
Dec 29, 2004·International Journal of Antimicrobial Agents·Jian LiKingsley Coulthard
Oct 27, 1999·Journal of the American Academy of Dermatology·M LandauM Giladi
Jul 16, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Elin Mogollon-PasaperaMarco Cassone
Feb 1, 1997·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Bruce A. Stewart
Apr 2, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P LespritL Deforges
Feb 18, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R ManfrediF Chiodo
Mar 16, 2005·New Zealand Veterinary Journal·P J Kelly
Dec 1, 2017·Clinical Microbiology Reviews·Cláudia Gomes, Joaquim Ruiz
May 12, 2017·Clinical Microbiology Reviews·Udoka OkaroBurt Anderson
Feb 9, 2006·The Journal of Antimicrobial Chemotherapy·S PendleJ Iredell
Apr 24, 2007·The Journal of Antimicrobial Chemotherapy·Silpak BiswasJean-Marc Rolain
Feb 23, 2019·The American Journal of Tropical Medicine and Hygiene·John C LamBonnie L Meatherall
Apr 20, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Florian BerteauUNKNOWN pour le Groupe d’Epidémiologie et Recherche en Infectiologie du Centre et de l’Ouest (GERICCO)
Oct 31, 1998·Antimicrobial Agents and Chemotherapy·J M BattistiM F Minnick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Cat-scratch disease

Cat-scratch disease, a relatively common infectious disease, is caused by Bartonella henselae and characterized by a fever and regional lymphadenitis. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bartonellosis

Bartonellosis is an infection caused by bacteria in the genus Bartonella and can present as a variety of diseases depending on the organism involved. While asymptomatic infection has been reported, immunocompromised individuals are more susceptible to severe infection. Find the latest research on bartonellosis here.